Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan

Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan
复制标题

DOI:
10.1183/13993003.congress-2020.1847
复制
发表时间:
2020-09
期刊:
Idiopathic interstitial pneumonias
影响因子:
--
通讯作者:
S. Hisata;M. Bando;S. Homma;K. Kataoka;T. Ogura;S. Izumi;S. Sakamoto;Yoshinobu Saito;Kizuku Watanabe;Y. Shimizu;Motoyasu Kato;N. Inase
S. Hisata;M. Bando;S. Homma;K. Kataoka;T. Ogura;S. Izumi;S. Sakamoto;Yoshinobu Saito;Kizuku Watanabe;Y. Shimizu;Motoyasu Kato;N. Inase
中科院分区:
其他
文献类型:
--
作者:
S. Hisata;M. Bando;S. Homma;K. Kataoka;T. Ogura;S. Izumi;S. Sakamoto;Yoshinobu Saito;Kizuku Watanabe;Y. Shimizu;Motoyasu Kato;N. Inase

文献摘要

相似文献